- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bhagiradha Chemicals has announced a board meeting that approved audited consolidated financial results for the quarter and year ending March 31, 2025. Revenue hit Rs. 440.47 Cr, with a PAT of Rs. 13.86 Cr, impacted by rising costs. A final dividend of Rs. 0.15 per share is declared. Leadership updates include the re-appointment of Chandra Sekhar Singavarapu as MD for five years and extensions for independent directors Kishor Shah and Dr. Gudipati Aruna. The preferential warrant issue raised Rs. 341.18 Cr, fully subscribed. Three promoter group members will be reclassified as public shareholders.
All announcements from Bhagiradha Chemicals & Industries Limited